MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-29-0017044
Retec Formulations Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹96,531
Latest filing
Net loss · FY 2025
₹7.09 Lakh
Latest filing
EBITDA · FY 2025
-₹7.04 Lakh
Latest filing
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹7.5 Lakh
Issued & subscribed
Open charges
₹1.33 Cr
Secured borrowings
Company age
28 yrs
Est. 1998
Directors on board
2
As per MCA filings
About Retec Formulations Private Limited
Data last updated:
Retec Formulations Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 February 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33110DL1998PTC092158. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7.5 Lakh. It is led by directors Anjani Kumar Pandey and Suvidha Pandey.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 25/5 Connaught Place, New Delhi, Delhi, India – 110001.
As per the financials filed for FY 2025, the company reported a revenue of ₹96,531. For the same year it recorded a net loss of ₹7.09 Lakh and EBITDA of -₹7.04 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 55% over five years.
The company is associated with 1 brand: Retec Group. As per MCA filings, the company has open charges of ₹1.33 Cr on record. Court records list 10 cases involving the company, including 10 filed against it; 3 cases are pending.
Retec Formulations Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-29-0017044). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website retecgroup.in.
Company Details of Retec Formulations Private Limited
CIN U33110DL1998PTC092158
Registration Number 092158
Incorporation Date 09 February 1998
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-29-0017044
CIN History of Retec Formulations Private Limited
Retec Formulations has one previous CIN (Corporate Identification Number): U99999DL1998PTC092158. The current CIN is U33110DL1998PTC092158, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U33110DL1998PTC092158 | Current |
| U99999DL1998PTC092158 | Previous |
Recognitions & Rankings of Retec Formulations
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressC – 25/5 Connaught Place, New Delhi, Delhi, India – 110001
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Retec Formulations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Retec Formulations Private Limited
Retec Formulations operates one associated brand: Retec Group. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Production of nutritional and pharmaceutical products focused on health improvement. | retecgroup.in |
Business Activity of Retec Formulations Private Limited
The main business activity of Retec Formulations is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Retec Formulations Private Limited FY 2025 filings available
Retec Formulations Private Limited reported revenue of ₹96,531 for FY 2025.
Revenue · FY 2025
₹96,531
Net loss · FY 2025
₹7.09 Lakh
EBITDA · FY 2025
-₹7.04 Lakh
Compounded Annual Growth Rate (CAGR) of Retec Formulations Private Limited
Revenue CAGR growth
5 years · compounded
▼ 55%
EBITDA CAGR growth
1 year
▼ 17%
3 years · compounded
▼ 110%
5 years · compounded
▲ 13%
Revenue has declined at a compounded annual rate (CAGR) of 55% over five years. EBITDA fell 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Retec Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹7.04 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹7.09 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Retec Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Retec Formulations are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Retec Formulations Private Limited
Retec Formulations has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anjani Kumar Pandey Also directs: Retec Healthcare Private Limited | Director | 09 Feb 1998 | 28 Years 8 Months | Current |
| Suvidha Pandey Also directs: Retec Healthcare Private Limited | Director | 09 Feb 1998 | 28 Years 8 Months | Current |
Peer Comparison of Retec Formulations Private Limited
Retec Formulations Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Brain 'N' Beyond Biotech Private Limited | ₹99,030 (FY 2023) | •••• | •••• | 120.0% | •••• | Bangalore, Karnataka, India |
| BLG Pharma Private Limited | ₹98,518 (FY 2025) | •••• | •••• | -9.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Shree Pharmaceuticals Private Limited | ₹97,345 (FY 2017) | •••• | •••• | -33.0% | •••• | Navi Mumbai, Maharashtra, India |
| Jayvisto Formulations Private Limited | ₹97,204 (FY 2024) | •••• | •••• | 525.0% | •••• | Patna, Bihar, India |
| Mediking Pharmaceuticals Private Limited | ₹97,100 (FY 2023) | •••• | •••• | •••• | Allahabad, Uttar Pradesh, India | |
| Retec Formulations Private Limited this company | ₹96,531 (FY 2025) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Oxeeco Meditek Private Limited | ₹96,499 (FY 2024) | •••• | •••• | 34.0% | •••• | Sanathnagar, Hyderabad, Telangana, India |
| Puneet Ventures Private Limited | ₹96,376 (FY 2025) | •••• | •••• | -99.0% | •••• | Indore, Madhya Pradesh, India |
| Analeptic Medic Private Limited | ₹95,631 (FY 2024) | •••• | •••• | •••• | Rajpura, Punjab, India | |
| Onlynutra Products Private Limited | ₹95,581 (FY 2025) | •••• | •••• | -45.0% | •••• | Meerut, Uttar Pradesh, India |
| Shuchi Healthcare Private Limited | ₹95,553 (FY 2025) | •••• | •••• | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Retec Formulations by revenue in the Pharma industry (Formulations, Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Retec Formulations Private Limited
Retec Formulations Private Limited is audited by RISHI KAPOOR AND COMPANY for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RISHI KAPOOR AND COMPANY | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Retec Formulations Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Retec Formulations Private Limited
Open charges
₹1.33 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 May 2013 | Oriental Bank of Commerce | ₹11 Lakh | Open |
| 01 Mar 2006 | Others | ₹1.2 Cr | Open |
| 16 Jun 1999 | Oriental Bank of Commerce | ₹2 Lakh | Open |
Total charge records: 3 View all charges
Legal Cases of Retec Formulations Private Limited
Retec Formulations Private Limited has 10 court cases on record: 10 filed against it. 3 cases are pending and 7 are disposed.
Total cases
10
Filed against the company
10
Pending
3
Disposed
7
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 10 | 3 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Magma Fincorp Limited | Pending |
| District court, East, Delhi | Criminal case | Filed against the company by Bogs India Pvt Ltd. | Disposed |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company | Pending |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Pharmabiz Inc | Pending |
| District court, Kamrup Metro, Assam | Revision petition | Filed against the company by M/S Patni Distributors Represented by Its Proprietor Ankit Patni | Disposed |
Premium access
Full case history
All 10 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Retec Formulations Private Limited
Employment history and EPFO contributions of people linked to Retec Formulations.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Retec Formulations Private Limited
Retec Formulations Private Limited has 3 board changes on record since 1998: 2 appointments and 1 cessation. The latest: Suman Lata Gupta ceased to be Director on 11 Nov 2011.
AGM
Retec Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Retec Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Others of Rs. 120.00 Lakh registered on 01 Mar 2006 with Charge ID 10002069 was modified on 20 Jun 2017.
Charges
A charge with Oriental Bank Of Commerce amounted to Rs. 11.00 Lakh with Charge ID 10428948 was registered on 14 May 2013.
Ceased
Suman Lata Gupta ceased to be Director.
Charges
A charge with Others amounted to Rs. 120.00 Lakh with Charge ID 10002069 was registered on 01 Mar 2006.
Charges
A charge with Oriental Bank Of Commerce of Rs. 2.00 Lakh registered on 16 Jun 1999 with Charge ID 90368429 was modified on 20 Aug 2000.
Charges
A charge with Oriental Bank Of Commerce amounted to Rs. 2.00 Lakh with Charge ID 90368429 was registered on 16 Jun 1999.
Appointed
Anjani Kumar Pandey was appointed as Director.
Appointed
Suvidha Pandey was appointed as Director.
Incorporation
09 Feb 1998
Retec Formulations Private Limited was registered on 09 Feb 1998 with Roc Delhi & aged 28 years 8 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Retec Formulations Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Retec Formulations Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Retec Formulations Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Retec Formulations Private Limited
Retec Formulations has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
Total GSTINs
1
Cancelled / inactive
1
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Retec Formulations Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Retec Formulations Private Limited
Retec Formulations is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 February 1998 (28+ years old) and is registered under CIN U33110DL1998PTC092158.
Retec Formulations reported revenue of ₹96,531 for FY 2025.
Retec Formulations has 2 current directors:
- Anjani Kumar Pandey - Director
- Suvidha Pandey - Director
Retec Formulations reported a net loss of ₹7.09 Lakh and EBITDA of -₹7.04 Lakh for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Retec Formulations is -55% over five years. CAGR is the steady yearly rate that links the first and the last year.
No. Retec Formulations has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Retec Formulations is U33110DL1998PTC092158. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Retec Formulations has 10 court cases on record: 10 filed against it. 3 are pending.
Retec Formulations was incorporated on 09 February 1998, making it 28+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Retec Formulations by revenue are Brain 'N' Beyond Biotech Private Limited, BLG Pharma Private Limited, Shree Pharmaceuticals Private Limited, Jayvisto Formulations Private Limited, Mediking Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharma Retail and Distribution).
Suman Lata Gupta ceased to be Director on 11 Nov 2011. Anjani Kumar Pandey was appointed as Director on 09 Feb 1998. Suvidha Pandey was appointed as Director on 09 Feb 1998.